Department of Clinical Pharmacology and Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Cancer Sci. 2014 Apr;105(4):396-401. doi: 10.1111/cas.12365. Epub 2014 Mar 17.
A mimotope is an antibody-epitope-mimicking peptide retrieved from a phage display random peptide library. Immunization with antitumor antibody-derived mimotopes is promising for inducing antitumor immunity in hosts. In this study, we isolated linear and constrained mimotopes from HBJ127, a tumor-suppressing anti-CD98 heavy chain mAb, and determined their abilities for induction of antitumor activity equal to that of the parent antibody. We detected elevated levels of antipeptide responses, but failed to detect reactivity against native CD98-expressing HeLa cells in sera of immunized mice. Phage display panning and selection of mimotope-immunized mouse spleen-derived antibody Fab library showed that HeLa cell-reactive Fabs were successfully retrieved from the library. This finding indicates that native antigen-reactive Fab clones represented an undetectable minor population in mimotope-induced antibody repertoire. Functional and structural analysis of retrieved Fab clones revealed that they were almost identical to the parent antibody. From these results, we confirmed that mimotope immunization was promising for retrieving antitumor antibodies equivalent to the parent antibody, although the co-administration of adjuvant compounds such as T-cell epitope peptides and Toll-like receptor 4 agonist peptides is likely to be necessary for inducing stronger antitumor immunity than mimotope injection alone.
拟态肽是从噬菌体展示随机肽文库中提取的抗体-表位模拟肽。用抗肿瘤抗体衍生的拟态肽进行免疫接种有望在宿主中诱导抗肿瘤免疫。在这项研究中,我们从肿瘤抑制性抗 CD98 重链 mAb HBJ127 中分离出线性和约束性拟态肽,并确定了它们诱导抗肿瘤活性的能力与亲本抗体相当。我们检测到抗肽反应水平升高,但未能在免疫小鼠的血清中检测到针对天然表达 CD98 的 HeLa 细胞的反应性。噬菌体展示淘选和选择模拟肽免疫的小鼠脾源性抗体 Fab 文库表明,已从文库中成功回收了针对 HeLa 细胞的 Fab。这一发现表明,天然抗原反应性 Fab 克隆在拟态肽诱导的抗体库中代表了一个难以检测的小群体。回收的 Fab 克隆的功能和结构分析表明,它们与亲本抗体几乎相同。从这些结果中,我们证实了拟态肽免疫是有希望回收与亲本抗体相当的抗肿瘤抗体的,尽管可能需要佐剂化合物(如 T 细胞表位肽和 Toll 样受体 4 激动肽)的共同给药,才能诱导比单独注射拟态肽更强的抗肿瘤免疫。